While no studies are available specifically addressing the expression of the remaining genes in hormonal migraine, Ibrahimi et al. determined that the significant increase in dermal blood flow response mediated by the product of CALCA, calcitonin gene-related peptide, in the menstrual cycle was lost in migraineurs, though no gene expression results were available [39]. The gene discussed is CALCA; the disease is migraine disorder.